Toyota global vehicle sales rise 7.5% in May
In the first five months of 2025, the group's global sales increased by 8.4% to 4,607,634 units, with sales in Japan surging by over 31% to 869,102 units, while overseas sales increased by just over 4% to 3,738,532 units.
Global sales of Toyota- and Lexus-branded vehicles increased by 6.2% to 4,291,376 units year-to-date, with sales in Japan rising by 14% to 641,418 units, while overseas sales rose by 4% to 2,857,823 units. Sales in North America increased by 4.2% to 1,210,878 units, while sales in Latin America (excluding Mexico) rose by 9.8% to 202,247 units. Sales in Asia (excluding Japan) rose by 5.8% to 1,264,728 units, reflecting strong growth in China, India, Vietnam, and the Philippines. In Europe, sales increased by just 1.9% to 506,766 units.
Toyota and Lexus reported a 21% rise in global sales of electrified vehicles to 2,083,953 units combined in the first five months of the year, accounting for almost 49% of total sales. Sales of battery electric vehicles (BEVs) rose by 10% to 65,065 units, which were almost entirely delivered to overseas clients, while sales of hybrid electric vehicles (HEVs) rose by 19% to 1,871,993 units.
Daihatsu's global sales rebounded by over 66% to 269,175 units year-to-date following last year's production stoppages, with sales in Japan surging by 150% to 212,149 units, while overseas sales plunged by 26% to 57,026 units.
The group's commercial vehicle unit, Hino Motors, reported a 3% drop in global sales to 47,083 units in this period, with sales in Japan falling by almost 6% to 15,535 units, while overseas sales declined by 2% to 31,548 units.
"Toyota global vehicle sales rise 7.5% in May" was originally created and published by Just Auto, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 minutes ago
- Yahoo
Allbirds Second Quarter 2025 Earnings: Beats Expectations
Explore Allbirds's Fair Values from the Community and select yours Allbirds (NASDAQ:BIRD) Second Quarter 2025 Results Key Financial Results Revenue: US$39.7m (down 23% from 2Q 2024). Net loss: US$15.5m (loss narrowed by 19% from 2Q 2024). US$1.92 loss per share (improved from US$2.45 loss in 2Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Allbirds Revenues and Earnings Beat Expectations Revenue exceeded analyst estimates by 2.8%. Earnings per share (EPS) also surpassed analyst estimates by 27%. Looking ahead, revenue is forecast to grow 4.2% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Luxury industry in the US. Performance of the American Luxury industry. The company's shares are down 27% from a week ago. Risk Analysis Before we wrap up, we've discovered 3 warning signs for Allbirds (1 is concerning!) that you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
11 minutes ago
- Yahoo
We're Not Very Worried About Odysight.ai's (NASDAQ:ODYS) Cash Burn Rate
Explore Fair Values from the Community and select yours There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although made losses for many years after listing, if you had bought and held the shares since 1999, you would have made a fortune. But while the successes are well known, investors should not ignore the very many unprofitable companies that simply burn through all their cash and collapse. Given this risk, we thought we'd take a look at whether (NASDAQ:ODYS) shareholders should be worried about its cash burn. In this article, we define cash burn as its annual (negative) free cash flow, which is the amount of money a company spends each year to fund its growth. First, we'll determine its cash runway by comparing its cash burn with its cash reserves. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. When Might Run Out Of Money? A company's cash runway is the amount of time it would take to burn through its cash reserves at its current cash burn rate. As at March 2025, had cash of US$37m and no debt. In the last year, its cash burn was US$9.3m. Therefore, from March 2025 it had 4.0 years of cash runway. A runway of this length affords the company the time and space it needs to develop the business. Depicted below, you can see how its cash holdings have changed over time. Check out our latest analysis for How Well Is Growing? At first glance it's a bit worrying to see that actually boosted its cash burn by 4.4%, year on year. Given that its operating revenue increased 100% in that time, it seems the company has reason to think its expenditure is working well to drive growth. If revenue is maintained once spending on growth decreases, that could well pay off! We think it is growing rather well, upon reflection. Clearly, however, the crucial factor is whether the company will grow its business going forward. So you might want to take a peek at how much the company is expected to grow in the next few years. Can Raise More Cash Easily? We are certainly impressed with the progress has made over the last year, but it is also worth considering how costly it would be if it wanted to raise more cash to fund faster growth. Generally speaking, a listed business can raise new cash through issuing shares or taking on debt. Commonly, a business will sell new shares in itself to raise cash and drive growth. By looking at a company's cash burn relative to its market capitalisation, we gain insight on how much shareholders would be diluted if the company needed to raise enough cash to cover another year's cash burn. Since it has a market capitalisation of US$72m, US$9.3m in cash burn equates to about 13% of its market value. Given that situation, it's fair to say the company wouldn't have much trouble raising more cash for growth, but shareholders would be somewhat diluted. How Risky Is Cash Burn Situation? It may already be apparent to you that we're relatively comfortable with the way is burning through its cash. For example, we think its revenue growth suggests that the company is on a good path. While its increasing cash burn wasn't great, the other factors mentioned in this article more than make up for weakness on that measure. After taking into account the various metrics mentioned in this report, we're pretty comfortable with how the company is spending its cash, as it seems on track to meet its needs over the medium term. On another note, we conducted an in-depth investigation of the company, and identified 4 warning signs for (2 can't be ignored!) that you should be aware of before investing here. Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies, and this list of stocks growth stocks (according to analyst forecasts) Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
25 minutes ago
- Yahoo
Axogen Second Quarter 2025 Earnings: Beats Expectations
Explore Axogen's Fair Values from the Community and select yours Axogen (NASDAQ:AXGN) Second Quarter 2025 Results Key Financial Results Revenue: US$56.7m (up 18% from 2Q 2024). Net income: US$579.0k (up from US$1.92m loss in 2Q 2024). Profit margin: 1.0% (up from net loss in 2Q 2024). The move to profitability was driven by higher revenue. EPS: US$0.013 (up from US$0.044 loss in 2Q 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period Axogen Revenues and Earnings Beat Expectations Revenue exceeded analyst estimates by 7.7%. Earnings per share (EPS) also surpassed analyst estimates. Looking ahead, revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 8.2% growth forecast for the Medical Equipment industry in the US. Performance of the American Medical Equipment industry. The company's shares are up 9.7% from a week ago. Risk Analysis You should learn about the 1 warning sign we've spotted with Axogen. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
